
zzso of zzso zzso zzso have generally been successful in inducing modest but statistically significant weight reductions in clinical zzso zzso is a new, highly selective inhibitor of zzso zzso It is effective and safe in zzso major depression at doses up to 60 zzso zzso In our study, 72 severely obese subjects zzso 44 zzso were instructed in a zzso zzso zzso zzso zzso The initial two week zzso zzso period was followed by a 12 week zzso period of zzso or zzso There were seven withdrawals during the initial two zzso Of the remaining 65 patients, 45 were zzso to 60 zzso zzso daily and 20 received zzso A trend towards a higher frequency of zzso at week 6 was noted in the zzso zzso Weight loss during the initial two weeks was zzso zzso In the following 12 weeks, mean weight loss was zzso zzso in the zzso group zzso zzso zzso in the zzso group zzso zzso zzso reductions occurring almost entirely during the initial four weeks of the treatment zzso We conclude that zzso is of no clinical value in the treatment of obesity when added to a zzso zzso zzso 

